HeartMate II
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $165,375 | 79 | 0 |
| 2019 | $94,839 | 92 | 0 |
| 2018 | $24,308 | 26 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $284,521 | 197 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| INvesTigation to OptimizE Hemodynamic Management of HeartMate II Left VentricuLar Assist DEvice Patients using the CardioMEMS Pulmonary ArTery Pressure Sensor in Advanced Heart Failure (INTELLECT 2-HF) | Abbott Laboratories | $157,223 | 0 |
| PREVENTion of Non-Surgical Bleeding by Management of HeartMate II Patients without Antiplatelet Therapy | Abbott Laboratories | $95,383 | 0 |
| Driveline Silicone Skin Interface Registry (SSI) | Abbott Laboratories | $29,213 | 0 |
| Remission From Stage D Heart Failure (RESTAGE-HF) | Abbott Laboratories | $2,702 | 0 |
Top Doctors Receiving Payments for HeartMate II
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Atlanta, GA | $284,521 | 197 |
Manufacturing Companies
- Abbott Laboratories $284,521
Product Information
- Type Device
- Total Payments $284,521
- Total Doctors 0
- Transactions 197
About HeartMate II
HeartMate II is a device associated with $284,521 in payments to 0 healthcare providers, recorded across 197 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2018 to 2020. In 2020, $165,375 was paid across 79 transactions to 0 doctors.
The most common payment nature for HeartMate II is "Unspecified" ($284,521, 100.0% of total).
HeartMate II is associated with 4 research studies, including "INvesTigation to OptimizE Hemodynamic Management of HeartMate II Left VentricuLar Assist DEvice Patients using the CardioMEMS Pulmonary ArTery Pressure Sensor in Advanced Heart Failure (INTELLECT 2-HF)" ($157,223).